Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Net Margin (2018 - 2025)

Neurogene's Net Margin history spans 6 years, with the latest figure at 28491.25% for Q1 2025.

  • For Q1 2025, Net Margin fell 52024208.0% year-over-year to 28491.25%; the TTM value through Dec 2025 reached 114972.5%, up 12305948.0%, while the annual FY2024 figure was 8184.43%, N/A changed from the prior year.
  • Net Margin reached 28491.25% in Q1 2025 per NGNE's latest filing, up from 1957.08% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 548733.33% in Q1 2024 to a low of 1957.08% in Q2 2024.
  • Average Net Margin over 3 years is 245991.88%, with a median of 218595.62% recorded in 2023.
  • Peak YoY movement for Net Margin: soared 14003333bps in 2024, then plummeted -52024208bps in 2025.
  • A 3-year view of Net Margin shows it stood at 408700.0% in 2023, then plummeted by -100bps to 1957.08% in 2024, then soared by 1556bps to 28491.25% in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Net Margin are 28491.25% (Q1 2025), 1957.08% (Q2 2024), and 548733.33% (Q1 2024).